Next-Generation Sequencing Analysis Software for Cell and Gene Therapy

BPI 2022, Vienna
May 17, 2022

Cell and gene therapies (CGT) rely on repurposed viruses as delivery and engineering systems. Their development, production and use are underpinned by complex processes, some of which can be uniquely supported by Next-Generation Sequencing (NGS). Genedata Selector^® software enables easy processing and analysis of these data.

Learn how Genedata Selector provides a single secure system for your NGS-based CGT development assays:

• Integrity analysis with provided clear go/no go thresholds enables faster and better-informed decisions
• Data traceability for all biosafety analyses enables report generation for internal and external audits
• Provided interactive tools unlock unique insight into the cell productivity and product potency